It will now be easier for pharmaceutical firms to develop infant medicines after Parliament's vote aimed at ending the current situation, under which most children take small doses of medication developed for adults, which may not correspond to their metabolism and can even be harmful.
Eiropas Parlaments atbalstīja regulu, kuras mērķis ir novērst pašreizējo praksi bērnu ārstēšanai lietot pieaugušo zāles, tikai mazākās devās.